![](/img/cover-not-exists.png)
Bipolar androgen therapy in men with metastatic castration-resistant prostate cancer after progression on enzalutamide: an open-label, phase 2, multicohort study
Teply, Benjamin A, Wang, Hao, Luber, Brandon, Sullivan, Rana, Rifkind, Irina, Bruns, Ashley, Spitz, Avery, DeCarli, Morgan, Sinibaldi, Victoria, Pratz, Caroline F, Lu, Changxue, Silberstein, John L, LLanguage:
english
Journal:
The Lancet Oncology
DOI:
10.1016/S1470-2045(17)30906-3
Date:
December, 2017
File:
PDF, 307 KB
english, 2017